Novel Imaging Approach Reveals Details About Rare Eye Disease
NEI intramural researchers have shown for the first time how cells across different tissue layers in the eye are affected in people with choroideremia, a rare genetic disorder that leads to blindness. The study—which combined traditional eye imaging techniques with adaptive optics, a technology that enhances imaging resolution—was published in Communications Biology.
Dr. Johnny Tam, head of the NEI clinical and translational imaging unit, combined adaptive optics with indocyanine green dye to view live cells in the retina, including light-sensing photoreceptors, retinal pigment epithelium (RPE) and choroidal blood vessels. His team was able to see in detail the extent to which choroideremia disrupts these tissues, providing information that could help design effective treatments for this and other eye diseases.
Choroideremia affects men more than women because the gene responsible for the disease is located on the X chromosome. Since males have only one copy of the X chromosome, a mutation in the gene causes males to develop more severe symptoms, while females—who have two copies of the X chromosome—usually have milder symptoms, having one working copy of the gene on the other X chromosome.
“One major finding of our study was that the RPE cells are dramatically enlarged in males and females with choroideremia,” said Tam. “We were surprised to see many cells enlarged by as much as five-fold.”
Tam’s adaptive optics is not part of routine diagnostic testing in eye clinics. Surprisingly, his team found that enlarged RPE cells can be detected even when using only a commercially available scanning laser ophthalmoscope along with indocyanine green dye.
“It’s not obvious at first, but using an existing tool in the clinic, we can monitor and track the cellular status of the RPE layer,” said Tam. “This could prove valuable in identifying which patients would benefit the most from therapeutic interventions.”